MENU
IGC
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

IGC Pharma (IGC) Ownership - Who owns IGC Pharma?

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer’s disease, period cramps, premenstrual syndrome, and chronic pain... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
70
Web
https://www.igcinc.us

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
26.68M
P/E Ratio
N/A
Total Cash
235K
Projected Growth
N/A
Total Debt
926K
Revenue
1.11M
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
15.73
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
IGC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
70
Web
https://www.igcinc.us